Committee Composition

Overview

Email Alerts
Charlotte's Web

Committee Composition Table
Member name	Audit Committee	Compensation Committee	Nominating and Corporate Governance Committee
Angela McElwee
William (Bill) Morachnick
Jeff Raborn
Matthew McCarthy
Maureen Usifer

Independent Director
Chairman of the Board
Director
Committee Member
Committee Chair

Investor Contact

Cory Pala

Investor Relations

Canada: (416) 594-3849
USA: (720) 484-8930

IR[at]charlottesweb.com

Charlotte's Web Holdings, INC.

For general questions & inquiries:

+1(855) 790-8169

700 Tech Court
Louisville CO 80027
United States

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Charlotte's Web, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Charlotte's Web to send you the requested Investor Email Alert updates.

* Required

Email Address *

Mailing Lists *

Press Release

Quarterly and Annual Reports

Events

Presentations

End of Day Stock Quote

Major League Baseball trademarks and copyrights are used with permission of Major League Baseball. Visit MLB.com.

Our Company

Overview
Stock Info

Financials
Governance

Press Releases
Events & Presentation

Investor Resources
Corporate Website

Our Company
Overview
Stock Info
Financials

Governance
Press Releases
Events & Presentation
Investor Resources
Corporate Website

* These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease.

§ This product is tested by high performance liquid chromatography to ensure it contains no more than 13 parts per million tetrahydrocannabinol (THC).